Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychosomatics 50:297-298, May-June 2009
doi: 10.1176/appi.psy.50.3.297
© 2009 Academy of Psychosomatic Medicine
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Andersohn, F.
* Articles by Garbe, E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Andersohn, F.
* Articles by Garbe, E.
Related Collections
* Antidepressants

Case Report

Citalopram-Induced Bleeding Due to Severe Thrombocytopenia

Frank Andersohn, M.D., Christine Konzen, M.D., Elisabeth Bronder, Ph.D., Andreas Klimpel, M.A., and Edeltraut Garbe, M.D., Ph.D.

Received October 19, 2007; revised December 13, 2007; accepted January 2, 2008. From the Bremen Institute for Prevention Research and Social Medicine (BIPS), Dept. of Clinical Epidemiology, Bremen, Germany; and the Charité, Universitaetsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Charitéplatz 1, 10117 Berlin, Germany. Send correspondence and reprint requests to Frank Andersohn, M.D., Institute for Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center, 10098 Berlin, Germany. e-mail: frank.andersohn{at}charite.de
© 2009 The Academy of Psychosomatic Medicine

BACKGROUND: In case reports and observational studies, serotonin reuptake-inhibitors (SSRIs) have been linked to an increased risk of bleeding, possibly due to platelet dysfunction as a consequence of serotonin-uptake blockade into platelets. OBJECTIVE: The authors propose that bleeding as a result of SSRI use may also be caused by other mechanisms. METHOD: Here, the authors report on a 32-year-old woman with hemorrhages resulting from severe drug-induced immune thrombocytopenia after 4 weeks of citalopram therapy. RESULTS: After withdrawal of citalopram and treatment with platelet concentrates and prednisolone, the patient recovered completely. CONCLUSION: As this case report shows, drug-induced immune thrombocytopenia may present another possible mechanism for bleeding in SSRI-treated patients.







Get information about faster international access.

Privacy Policy

Copyright © 2009 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org